Diastolic heart failure

Maria Frigerio1, Giovanni Aguggini

  • 1Division of Cardiology 2, A. De Gasperis Cardio-Thoracic-Vascular Department, Nigularda Ca' Granda Hospital, Milan, Italy. maria.frigerio@ospedaleniguarda.it

Insights

Diastolic heart failure, characterized by preserved left ventricular ejection fraction (LVEF), is common in the elderly. While mortality is lower than other heart failure types, morbidity remains high, necessitating empirical treatments.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Diastolic heart failure (DHF) is defined by preserved left ventricular ejection fraction (LVEF).
  • It is a common and heterogeneous condition, particularly prevalent in the elderly, accounting for up to 50% of heart failure cases in this demographic.
  • While DHF generally has lower mortality rates compared to heart failure with reduced LVEF, its morbidity is substantial.

Purpose of the Study:

  • To summarize the characteristics and current treatment approaches for diastolic heart failure.

Main Methods:

  • Review of existing literature and clinical guidelines on diastolic heart failure.
  • Emphasis on diagnostic methods like Doppler echocardiography for identifying diastolic dysfunction.
  • Discussion of pharmacological interventions used in managing DHF.

Main Results:

  • Diastolic dysfunction is a key diagnostic criterion for DHF, often identified via Doppler echocardiography.
  • Heart failure with preserved LVEF is particularly common in older adults.
  • Treatment strategies are empirical, focusing on hemodynamic management and disease progression control.

Conclusions:

  • Diastolic heart failure presents unique challenges due to its high morbidity despite lower mortality.
  • Current treatments are empirical and focus on symptom management and hemodynamic stabilization.
  • Further research into targeted therapies for DHF is warranted.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...